OneChain Immunotherapeutics
Sergi Casadó Llombart is a scientist at OneChain Immunotherapeutics, having started in January 2023. Prior to this role, Sergi worked as a postdoctoral researcher at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) from March 2022 to December 2022, and as a predoctoral researcher at the same institution from October 2016 to December 2021, focusing on the role of scavenger receptors in autoimmune diseases and cancer. Additionally, Sergi gained experience as a visiting researcher at the University Hospital Basel in 2019 and as an MSc student at IDIBAPS and Vall d’Hebron Institute of Research in 2015. Sergi holds a Doctor of Philosophy in Biomedicine, a Master's degree in Biomedicine, and a Bachelor's degree in Biochemistry, all from Universitat de Barcelona.
This person is not in any teams
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.